We are live on
!
Find out more
SP
Syncona Portfolio Portfolio holdings
AUM
$25.7M
1-Year Est. Return
13.32%
This Fund
S&P 500
This Quarter
Est. Return
-34.45%
1 Year Est. Return
+13.32%
3 Year Est. Return
+8.47%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$26.4M
AUM Growth
-$26.6M
(-50%)
Cap. Flow
-$12.6M
Cap. Flow
% of AUM
-47.93%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ACHL
Achilles Therapeutics
ACHL
|
+$12.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
BAM
FCC
BWG
LTM
TCM
BH
BCM
BCM
Syncona Portfolio's Q1 2025 Portfolio in Review
As of Q1 2025, Syncona Portfolio held 3 positions worth $26.4M, down 50% from $53M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Syncona Portfolio withdrew a net $12.6M in Q1 2025, closing 1 position. Its most notable exit was Achilles Therapeutics, an estimated $12.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Syncona Portfolio fully exited Achilles Therapeutics in Q1 2025, selling an estimated $12.6M.
- Syncona Portfolio's ten largest holdings make up 100% of its $26.4M portfolio in Q1 2025.
- Syncona Portfolio opened 0 new positions and closed 1 in Q1 2025.
- Syncona Portfolio's portfolio value fell 50% quarter-over-quarter to $26.4M.
Based on Syncona Portfolio's 13F filing for Q1 2025, filed 7 May 2025.